Roth Capital Assumes bluebird bio (BLUE) at Buy
Tweet
Share
E-mail
Get Alerts BLUE Hot Sheet
Price: $4.97 --0%
Rating Summary:
10 Buy, 19 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 7 | New: 31
Rating Summary:
10 Buy, 19 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 7 | New: 31
Join SI Premium – FREE
Roth Capital assumed coverage on bluebird bio (NASDAQ: BLUE) with a Buy rating and a price target of $87.00.
For an analyst ratings summary and ratings history on bluebird bio click here. For more ratings news on bluebird bio click here.
Shares of bluebird bio closed at $73.81 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- B.Riley Starts Suncrete Inc (RMIX) at Buy
- Lucid Capital Markets Starts Palmer Square Capital BDC (PSBD) at Neutral
- Litchfield Hills Starts NextPlat (NXPL) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
Roth CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
